REGENXBIO Inc.RGNXNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank83
3Y CAGR-1.0%
5Y CAGR+5.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-1.0%/yr
vs +23.3%/yr prior
5Y CAGR
+5.4%/yr
Recent deceleration
Acceleration
-24.3pp
Decelerating
Percentile
P83
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$82.86M+8.1%
2024$76.62M-13.4%
2023$88.49M+3.8%
2022$85.28M+7.5%
2021$79.33M+24.3%
2020$63.82M+23.2%
2019$51.81M+40.6%
2018$36.85M+35.3%
2017$27.23M+15.4%
2016$23.59M-